36 participants
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-01
- Start Date:
- 2022-07-30
- Completion:
- 2026-07-31
Conditions
- Glioblastoma Multiforme
- Recurrent Glioblastoma
Interventions
- DEVICE
No Results Yet